FLAIR 在 MRI 阴性的库欣病中的潜在应用价值
该前瞻性研究分析了 23 例经生化证实库欣病患者的 24 个肿瘤,术前均行增强 FLAIR 与增强 3D-GRE 序列。3D-GRE 单独检出 18 个(75%),FLAIR 正确识别 13 个(50%);5 例 3D-GRE 阴性患者中 FLAIR 均见强化灶,其中 4 例(80%)病理位置一致并获术后生化缓解。作者提出在 3D-GRE 基础上加做增强 FLAIR 以辅助手术规划。
要点
- 3D-GRE 检出 24 个垂体腺瘤中的 18 个(75%,灵敏度 82%,阳性预测值 95%)。
- FLAIR 正确识别 13 个(50%,1 例假阳性;灵敏度 55%,阳性预测值 92%)。
- 5 例 3D-GRE 阴性者 FLAIR 均见强化灶,4 例(80%)病理位置一致并获生化缓解。
核心结论
- 作者认为延迟的微腺瘤对比剂廓清可能在 MRI 阴性库欣病中表现为 FLAIR 高信号,并提出在 3D-GRE 基础上加做增强 FLAIR 序列以辅助手术规划。
研究设计与样本
- 前瞻性分析 23 例经生化证实库欣病、接受经蝶手术患者的 24 个肿瘤,术前均行垂体 MRI 增强 FLAIR 与增强 3D-GRE 序列。
主要发现
- 24 个垂体腺瘤中 3D-GRE 检出 18 个(75%;灵敏度 82%,阳性预测值 95%),FLAIR 正确识别 13 个(50%;1 例假阳性;灵敏度 55%,阳性预测值 92%)。
- 3D-GRE 与 FLAIR 的单独特异度相似(50%)。
- 5 例 3D-GRE 阴性患者 FLAIR 均显示明确强化灶,其中 4 例(80%)病理位置一致并获术后生化缓解。
- 剩余 1 例未治愈,因切除范围未包括 FLAIR 高信号区域。
关键数值与推荐
- 3D-GRE 检出 18/24(75%;灵敏度 82%,阳性预测值 95%)。
- FLAIR 正确识别 13/24(50%;1 例假阳性;灵敏度 55%,阳性预测值 92%)。
- 3D-GRE 与 FLAIR 单独特异度均为 50%。
临床怎么用
- 作者提出在库欣病患者手术规划中,于 3D-GRE 基础上加做增强 FLAIR 序列作为补充工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE Accurate presurgical localization of microadenomas in Cushing's disease (CD) leads to improved remission rates and decreased adverse events. Volumetric gradient recalled echo (3D-GRE) MRI detects pituitary microadenomas in CD in up to 50%-80% cases as a focus of hypointensity due to delayed contrast wash-in. The authors have previously reported that postcontrast FLAIR imaging may be useful in detecting otherwise MRI-negative pituitary microadenomas as foci of hyperintensity. This reflects theoretically complementary imaging of microadenomas due to delayed contrast washout. The authors report on the diagnostic accuracy and clinical utility of FLAIR imaging in the detection of microadenomas in patients with CD. METHODS The authors prospectively analyzed imaging findings in 23 patients (24 tumors) with biochemically proven CD who underwent transsphenoidal surgery for CD. Preoperatively, the patients underwent pituitary MRI with postcontrast FLAIR and postcontrast 3D-GRE sequences. RESULTS Postcontrast FLAIR hyperintensity was detected in macroadenomas, and in 3D-GRE-positive or -negative microadenomas. Overall, 3D-GRE was superior in detecting surgically and histopathologically confirmed, location-concordant microadenomas. Of 24 pituitary adenomas, 18 (75%; sensitivity 82%, positive predictive value 95%) were found on 3D-GRE, and 13 (50% [1 was false positive]; sensitivity 55%, positive predictive value 92%) were correctly identified on FLAIR. The stand-alone specificity of 3D-GRE and FLAIR was similar (50%). These results confirm the superiority of 3D-GRE as a stand-alone imaging modality. The authors then tested the utility of FLAIR as a complementary tool to 3D-GRE imaging. All 5 patients with negative 3D-GRE MRI displayed a distinct focus of FLAIR enhancement. Four of those 5 cases (80%) had location-concordant positive histopathological results and achieved postsurgical biochemical remission. The remaining patient was not cured, because resection did not include the region of FLAIR hyperintensity. CONCLUSIONS This study suggests that delayed microadenoma contrast washout may be detected as FLAIR hyperintensity in otherwise MRI-negative CD cases. The authors propose adding postcontrast FLAIR sequences to complement 3D-GRE for surgical planning in patients with CD. Clinical trial registration no.: NIH protocol 03-N-0164, NCT00060541 (clinicaltrials.gov).
引用
- Chatain GP, Patronas N, Smirniotopoulos JG, et al. Potential utility of FLAIR in MRI-negative Cushing's disease. J Neurosurg. 2017. PMID: 29027863. doi:10.3171/2017.4.JNS17234
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。